Medicinal cannabis adverse event study provides useful early warnings, but with limitations by Dr Teresa Nicoletti and Geoff Bloom May 7, 2026May 7, 2026 Mills Oakley partners Dr Teresa Nicoletti and Geoff Bloom unpack recent analysis of adverse events linked […]
TGA finalising safety report that could shape reform proposals by Steve Jones April 22, 2026April 22, 2026
‘Growers can’t just stop what they’re doing’. New cultivators guild chair takes aim at long ODC approval times by Adam Sheldon April 9, 2026April 14, 2026
News in brief: Montu, TGA back in court in June; Vitura advisory board chair resigns by Steve Jones April 9, 2026April 10, 2026
THC rescheduling process ‘already in motion’ as industry urged ‘to get ready to respond’ by Steve Jones April 2, 2026April 2, 2026
Court adjourns Montu case again as proceedings approach second anniversary by Steve Jones March 24, 2026March 25, 2026
Lancet clinical review paper: why absence of evidence is not evidence of absence by Andrew Proudfoot March 18, 2026March 18, 2026
Meet the appointed members of the scheduling committee who could shape THC’s regulatory future by Adam Sheldon and Steve Jones March 18, 2026March 19, 2026
